OMXHEX:REG1V   REVENIO GROUP CORPORATION
Revenio is a global leader in ophthalmic diagnostics and ophthalmic devices. The Revenio Group's eye diagnostic solutions under the iCare brand include intraocular pressure measuring devices, fundus imaging devices and perimeters. The main tools for identifying, diagnosing and monitoring glaucoma during treatment are intraocular pressure measurement (tonometry), fundus imaging and visual field examination (perimetry).

Key figures
Year 2021e 2022e 2023e 2024e
growth% 27.3% 25.5% 23.8% 23.1%
EBIT-% 28.1% 31.4% 34.3% 35.0%
Dividend% 0.9% 1.2% 1.4% 2.0%
ROI-% 23% 30% 35% 37%
(prediction figures from inderes.fi, not mine)

Increased my position by 25%. Still fundamentally strong.
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.